Spruce Biosciences, Inc. (SPRB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:25AM EDT. Market open.
| Previous close | 0.7100 |
| Open | 0.7000 |
| Bid | 0.6944 x 200 |
| Ask | 0.7233 x 200 |
| Day's range | 0.7000 - 0.7187 |
| 52-week range | 0.6710 - 5.9500 |
| Volume | |
| Avg. volume | 1,361,072 |
| Market cap | 29.013M |
| Beta (5Y monthly) | 2.53 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.2400 |
| Earnings date | 13 May 2024 - 17 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 2.75 |
Business WireSpruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
SOUTH SAN FRANCISCO, Calif., April 22, 2024--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that a submitted abstract was accepted for poster presentation at the Pediatric Endocrine Society (PES) 2024 Annual Meeting taking place May 2-5, 2024, in Chicago, IL.
ZacksSpruce Biosciences (SPRB) Upgraded to Buy: Here's What You Should Know
Spruce Biosciences (SPRB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Simply Wall St.Revenue Downgrade: Here's What Analysts Forecast For Spruce Biosciences, Inc. (NASDAQ:SPRB)
The latest analyst coverage could presage a bad day for Spruce Biosciences, Inc. ( NASDAQ:SPRB ), with the analysts...
© 2024 Yahoo. All rights reserved.